Some folks on our side are too quick to throw every death they see online into the "died suddenly" column. I understand that temptation - but let's stick to confirmed vax deaths.
No - not VAERS data (Team Fauci always roll their eyes when we mention VAERS). It’s ridiculous and unfair since the CDC and FDA refer to VAERS all the time but let’s play by their rules for just a moment. Let’s use data they CANNOT refute - I'm talking about ACTUAL case reports with autopsies around the world.
A case report frequently dives deep into the death of an individual who died under medical circumstances of interest - so these are representative cases with significance and probably represent broader vaccine injury issues in the general populace.
If anyone dismisses your data on VAERS or V-SAFE (because they’re just being silly) then throw one of these at them!
On top of that, the source that I’m using provides over 3267 other case reports including.
Myocarditis Case Reports: 391
Hematological Case Reports: 671
Skin Condition Case Reports: 540
Immunity / Misc Case Reports: 942
Neurological Case Reports: 555
Lymphadenopathy Case Reports: 125
Here are 33 confirmed vaccine-related deaths in the form of case reports.
Aug 2021 - study in Italy examined 2 fatal cases of vaccine-induced thrombotic thrombocytopenia post ChAdOx1 nCoV-19 vaccination. Findings suggest a vaccine-triggered autoimmune reaction causing widespread venous thrombosis & multi-organ damage. High mortality rate observed. 🔬🩸 https://doi.org/10.3324/haematol.2021.279075
Dec 2022 - 27-year-old man suffers rare fatal fulminant myocarditis 8 days after mRNA COVID-19 vaccination. Autopsy reveals significant mixed inflammatory infiltration. Steroid therapy could be effective in such cases. https://pubmed.ncbi.nlm.nih.gov/35812802
Oct 2022 - 61-year-old woman with no significant medical history experienced fatal fulminant myocarditis after SARS-CoV-2 vaccination; autopsy shows severe myocarditis with extensive myocytolysis, highlights need to study immune reactions post-vaccination. https://pubmed.ncbi.nlm.nih.gov/36040128
Mar 2023 - 67-year-old woman in Japan dies after BNT162b2 mRNA vaccine. Autopsy reveals TMA-like multiple systemic thrombi, mostly in the heart. Cause-effect relationship uncertain, careful follow-up post-vaccination advised. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540301/
Aug 2022 - Autopsy study of 2 teens post 2nd Pfizer-BioNTech #COVID19Vaccine reveals myocardial injury resembling catecholamine-induced stress cardiomyopathy, not typical myocarditis. https://meridian.allenpress.com/aplm/article/doi/10.5858/arpa.2021-0435-SA/477788/Autopsy-Histopathologic-Cardiac-Findings-in-Two
Oct 2021 - Dresden, Germany: 77-year-old man with Parkinson's disease passed away three weeks after receiving his third COVID-19 vaccine. Autopsy revealed neurological and cardiac inflammation linked to the vaccine
https://www.preprints.org/manuscript/202206.0308/v2Oct 2021 - South Korea - A 22-year-old man experienced sudden cardiac death 5 days after receiving the first dose of the BNT162b2 mRNA COVID-19 vaccine. Autopsy revealed isolated atrial myocarditis, with neutrophil and histiocyte predominance, causally-associated with the vaccine.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524235/March 2022: Fatal case of thrombotic thrombocytopenia in 37-year-old woman 11 days after receiving ChAdOx1 nCoV-19 vaccine. Autopsy reveals cerebral venous thrombosis and strong inflammatory response. Study emphasizes need for multidisciplinary approach.
https://doi.org/10.1016/j.prp.2022.153796Jan 2022 - USA - 32M experiences sudden death due to severe heart inflammation. Immune cells (eosinophils) attack heart muscle, causing fatal damage. https://journals.lww.com/amjmedsci/Citation/2023/03000/Fatal_Fulminant_Necrotizing_Eosinophilic.15.aspx
Aug 2021 - Italy - 58M develops severe thrombotic thrombocytopenia (VITT) after first dose of AstraZeneca COVID-19 vaccine, leading to fatal multiple organ failure. Thrombi found in various organs, including a new finding of cerebral thrombosis in choroid plexuses. https://www.europeanreview.org/article/26464
Oct 2021: French case study of a 62-year-old man who developed cerebral venous sinus thrombosis and died 13 days after receiving ChAdOx1 nCov-19 vaccine. High levels of IgG anti-platelet factor 4 antibodies were found, confirming vaccine-induced immune thrombotic thrombocytopenia (VITT). Heparin and platelet transfusion worsened the disease. https://bit.ly/3jYRN6U
Nov 2021: A case study of a 57-year-old man in Japan who developed severe rhabdomyolysis and multiple thrombosis after receiving the first dose of mRNA-1273 vaccine. Despite intensive care, the patient died of multiple organ failure. Autopsy revealed multiple thrombosis in arterioles and organ necrosis, suggesting a possible immune-mediated mechanism. This is the first case report of rhabdomyolysis and multiple thrombosis of arterioles following a COVID-19 vaccination. https://bit.ly/3jYRN6U
Nov 2021: A 38-year-old man with multiple myeloma in South Korea died of hypotensive shock 2.5 days after receiving the Ad26.COV2.S vaccine. Findings suggested systemic capillary leak syndrome (SCLS) as the cause, and the patient had a history of a suspected flare episode. Clinicians should be aware of possible SCLS in at-risk populations before administering the vaccine. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544977/
Apr 2021: Previously healthy woman in her 30s in Norway developed fatal cerebral hemorrhage 10 days after receiving AstraZeneca's ChAdOx1 nCoV-19 vaccine. Severe thrombocytopenia and antibodies to PF4 indicate likely diagnosis of vaccine-induced immune thrombotic thrombocytopenia (VITT).
https://tidsskriftet.no/en/2021/04/kort-kasuistikk/fatal-cerebral-haemorrhage-after-covid-19-vaccineOct 2021: Case study in Japan reports a 62-year-old woman developed lymphohistocytic myocarditis after receiving the Ad26.COV2.S (Johnson & Johnson) COVID-19 vaccine, resulting in severe biventricular cardiomyopathy and death. This is the first reported case suggesting a potential link between viral vector vaccines and cardiac involvement.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421108/May 2022: 31-year-old man in Croatia developed thrombocytopenia and fatal intracranial hemorrhage after receiving ChAdOx1 nCoV-19 (AstraZeneca) vaccine. `https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113779/
Nov 2021: Fatal case of MIS-A in Tennessee, USA, in a man in his 30s after natural SARS-CoV-2 infection and full COVID-19 vaccination. The patient experienced fever, inflammation, neurologic and mucocutaneous symptoms, and severe cardiac illness. Autopsy revealed capillaritis and multiorgan microvascular thrombosis. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544993/
Aug 2021: Two cases of malignant cerebral infarction with thrombocytopenia reported in Italy after ChAdOx1 nCoV-19 vaccination. Both patients, women aged 57 and 55, developed arterial brain thrombosis, venous thrombosis, and high levels of antibodies against platelet factor 4, suggestive of a rare variant of vaccine-induced immune thrombotic thrombocytopenia (VITT).
Here are another 15 case studies which are not autopsies but still significant and relevant.
6/8/21; Location: Italy; Sex: 1 male and 1 female (1/2 died); Age: 55 and 57. The case study describes two individuals who suffered from malignant cerebral infarction after receiving the ChAdOx1 nCov-19 vaccine. Link: https://pubmed.ncbi.nlm.nih.gov/34341358/
7/16/21; Location: Korea; Sex: 1 male (died); Age: 33. The case study reports the first fatal case of intracerebral hemorrhage due to thrombosis with thrombocytopenia syndrome after COVID-19 vaccination in Korea. Link: https://pubmed.ncbi.nlm.nih.gov/34402235/
6/14/21; Location: Belgium; Sex: 1 female (died); Age: 37. The case study reports the first documented case of fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) outside the US, after the Ad26.COV2.S vaccine. Link: https://pubmed.ncbi.nlm.nih.gov/34626338/
9/1/21; Location: Nevada; Sex: 1 female (died); Age: 60. The case study reports a vaccinated patient with COVID-19 infection who died of brain death. Link: https://pubmed.ncbi.nlm.nih.gov/34656887/
Date: Not reported; Location: Taiwan; Sex: 1 case; Age: 1. The case study describes a case of fatal myositis, rhabdomyolysis, and compartment syndrome after ChAdOx1 nCoV-19 vaccination. Link: https://pubmed.ncbi.nlm.nih.gov/35504826/
12/1/21; Location: Korea; Sex: 1 male (died); Age: 63. The case study reports a case of heart transplantation for fulminant myocarditis after ChAdOx1 nCoV-19 vaccination. Link: https://pubmed.ncbi.nlm.nih.gov/35380028/
4/9/21; Location: Germany, Austria; Sex: 2 males and 9 females (6/11 died); Age: 22-49. The case study reports 11 cases of thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. Link: https://pubmed.ncbi.nlm.nih.gov/33835769/
4/9/21; Location: Norway; Sex: 1 male and 4 females (3/5 died); Age: 32-54. The case study reports 5 cases of thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Link: https://pubmed.ncbi.nlm.nih.gov/33835768/
4/16/21; Location: UK; Sex: 9 males and 14 females (7/23 died); Age: 21-77. The case study reports 23 cases of pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. Link: https://pubmed.ncbi.nlm.nih.gov/33861525/
4/27/21; Location: UK; Sex: 1 male and 2 females (1/3 died); Age: 35-43. The case study reports three cases of ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immuneDate: 7/21/21; Location: Denmark; Sex: 1 male (died); Age: 57. The case study reports a case of intracerebral hemorrhage twelve days after vaccination with ChAdOx1 nCoV-19. https://pubmed.ncbi.nlm.nih.gov/34035134/https://pubmed.ncbi.nlm.nih.gov/34477089/
6/6/21; Location: Norway; Sex: 5 females (4/5 died) and 0 males; Age: 34-54. The case series reports five cases of vaccine-induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with high fatality rate. Link: https://pubmed.ncbi.nlm.nih.gov/34393988/
Date: Not reported; Location: Germany; Sex: 2 cases, 0 males, 0 females; Age: 1-2. The case series reports two cases of acute hemorrhagic encephalomyelitis after SARS-CoV-2 vaccination. Link: https://pubmed.ncbi.nlm.nih.gov/35185757/
Date: Not reported; Location: New York; Sex: 3 cases, 0 males, 0 females; Age: 2-3. The case series reports three cases of new-onset CNS inflammatory disorders temporally associated with mRNA-based SARS-CoV-2 vaccines. Link: https://pubmed.ncbi.nlm.nih.gov/35280277/
Date: 11/12/21; Location: India; Sex: 1 female (died); Age: 18. The case report describes a case of vaccine-induced thrombotic thrombocytopenia due to COVID-19 vaccine from a deceased donor. Link: https://pubmed.ncbi.nlm.nih.gov/34916063/
Justin - are you familiar with John Beaudoin and his efforts in Massachusetts?
Horrfyingly impressive.